However, while great progress has been achieved in measuring several soluble p-tau species capable of tracking AD pathology in vivo [1], p-tau205 and p-tau202 remain comparatively under-explored as viable fluid biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.